Strikingly, we find that postnatal ketanserin treatment blocks both the MS-evoked changes in prefrontal 5-HT2A mRNA expression in postnatal life, as well as the emergence of anxiety behavior following MS in adulthood. The gene discussed is HTR2A; the disease is Anxiety.